42.0.0.26 – Redirect Fix (Removed pre-redirect output)
DEBUG LOG – klik om te openen
=== VARIABELEN ===
Array
(
[defid] => VWS-WOO-08-638799
[request_id] =>
)
=== SQL LOG ===
Geen SQL queries.
Huidig document record
Array
(
[id] => 65e9e5f8-202d-4022-8a2f-01d7b71ff6be
[Document ID] => 638799
[Document naam] => Valneva COVID.docx
[Bestandsnaam] =>
[Beoordeling] =>
[Beoordelingsgrond] =>
[Toelichting] =>
[Publieke link] =>
[Locatie open.minvws.nl] => https://open.minvws.nl/dossier/VWS-WOO/3324842-1025145-wjz/document/VWS-WOO-08-638799
[Opgeschort] =>
[Definitief ID] => VWS-WOO-08-638799
[Status] => shiningstar
[FromFile] => https://open.minvws.nl/dossier/VWS-WOO/3324842-1025145-wjz
[DocumentPublicationDate] => 16 september 2020
[DocumentStatusCheckedDate] => 2026-04-28 05:44:15.271317
[DocumentStatusCheckedResult] => 200
[SourceFileType] =>
[Tags] =>
[Besluit] =>
[ModifiedDate] => 2025-09-22 02:59:35
[DeletedDate] =>
[BesluitURL] =>
[CreatedDate] => 2025-06-19 18:31:59
[DocumentDownloadLink] =>
[DigestLaatsteControleDatum] => 2025-09-22 02:59:35
)
Document: VWS-WOO-08-638799
Klik om te vergroten
Document correcties
Geregistreerde datum: 20200916
Geregistreerde documentnaam: Valneva COVID.docx
Document attributen
| Tag | Waarde | Datum |
|---|---|---|
| Request_Omvang publicatie_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3324842-1025145-wjz/file/download/inventory | 2026-03-11 03:39:08 |
| Request_Omvang publicatie_paginas | 8.342 | 2026-03-11 03:39:08 |
| Request_Omvang publicatie_linkname_1 | Inventarislijst | 2026-03-11 03:39:08 |
| Request_Omvang publicatie | 8.342 documenten waarvan 4.012 openbaar gemaakt Inventarislijst | 2026-03-11 03:39:08 |
| About_Gelakte gegevens | 10.2a Internationale betrekkingen Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten | 2025-09-01 20:04:48 |
| About_Gelakte gegevens_linkhref_2 | mailto:DienstpostbusDatalekkenDoo@minvws.nl | 2025-09-01 20:04:48 |
| document_SectionDownloadButton | 1 | 2025-09-01 20:04:48 |
| Request_Omvang openbaarmaking_linkname_1 | Inventarislijst | 2025-06-30 04:09:14 |
| document_documentName | Valneva COVID.docx | 2025-06-30 04:09:14 |
| document_documentType | Word-document | 2025-06-30 04:09:14 |
| document_documentPublicationDate | 2020-09-16 | 2025-06-30 04:09:14 |
| document_documentNumber | VWS-WOO-08-638799 | 2025-06-30 04:09:14 |
| document_SectionHTMLDataDivs | 3 | 2025-06-30 04:09:14 |
| document_SectionAbout | 1 | 2025-06-30 04:09:14 |
| About_Datum document | 16 september 2020 | 2025-06-30 04:09:14 |
| About_Type bronbestand | Word-document, 1 pagina's | 2025-06-30 04:09:14 |
| About_Type bronbestand_paginas | 1 | 2025-06-30 04:09:14 |
| About_Download als | PDF (236.26 KB) | 2025-06-30 04:09:14 |
| About_Documentnummer | 638799 | 2025-06-30 04:09:14 |
| About_Beoordeling | Gedeeltelijke openbaarmaking | 2025-06-30 04:09:14 |
| About_Gelakte gegevens_linkhref_1 | https://wetten.overheid.nl/BWBR0005252/2018-07-28#HoofdstukV | 2025-06-30 04:09:14 |
| About_Gelakte gegevens_linkname_1 | 10.2a Internationale betrekkingen | 2025-06-30 04:09:14 |
| About_Gelakte gegevens_linkname_2 | Laat het ons weten | 2025-06-30 04:09:14 |
| document_SectionRequest | 1 | 2025-06-30 04:09:14 |
| Request_Onderdeel van | Wob-deelbesluit aangaande Vaccinaties en medicatie over de periode september 2020 | 2025-06-30 04:09:14 |
| Request_Onderdeel van_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3324842-1025145-wjz | 2025-06-30 04:09:14 |
| Request_Onderdeel van_linkname_1 | Wob-deelbesluit aangaande Vaccinaties en medicatie over de periode september 2020 | 2025-06-30 04:09:14 |
| document_SectionDownloadButton | 0 | 2025-06-30 04:09:14 |
| Request_Periode | September 2020 | 2025-06-30 04:09:14 |
| Request_Type besluit | Wob-besluit | 2025-06-30 04:09:14 |
| Request_Datum besluit | 25 februari 2022 | 2025-06-30 04:09:14 |
| document_SectionHistory | 1 | 2025-06-30 04:09:14 |
| Request_Samenvatting verzoek | De minister van Volksgezondheid, Welzijn en Sport heeft op 25 februari 2022 een besluit genomen op verzoeken in het kader van de Wet openbaarheid van bestuur. Het besluit betreft openbaarmaking van documenten die betrekking hebben op informatie aangaande Vaccinaties en medicatie over de periode september 2020. | 2025-06-30 04:09:14 |
| About_Gelakte gegevens | 10.2a Internationale betrekkingen Komt u in dit document gegevens tegen waarvan u denkt dat deze gelakt hadden moeten worden? Of is het document slecht leesbaar? Laat het ons weten. | 2025-06-30 04:09:14 |
| About_Gelakte gegevens_linkhref_2 | mailto:_dienstpostbusWoo-corona-ondersteuning@minvws.nl?subject=Opmerking over Valneva COVID.docx (documentnummer 1ef8fb28-e67c-63d6-93d3-fb42b720b124) | 2025-06-30 04:09:14 |
| Request_Omvang openbaarmaking | 8.330 documenten, 23.793 pagina's Inventarislijst | 2025-06-30 04:09:14 |
| Request_Omvang openbaarmaking_documenten | 8.330 | 2025-06-30 04:09:14 |
| Request_Omvang openbaarmaking_paginas | 23.793 | 2025-06-30 04:09:14 |
| Request_Omvang openbaarmaking_linkhref_1 | https://open.minvws.nl/dossier/VWS-WOO/3324842-1025145-wjz/file/download/inventory | 2025-06-30 04:09:14 |
| History Actie_1 | Bronbestand toegevoegd (pdf, 236.26 KB) | 2025-06-21 00:40:07 |
| History Datum_1 | 21 oktober 2024 16:34 | 2025-06-21 00:40:07 |
| DocumentDownload_proposed_filename (lokale kopie) | VWS-WOO-08-638799.pdf | 2025-04-19 13:40:32 |
| DocumentDownload_linkhref | https://open.minvws.nl/dossier/VWS-WOO/3324842-1025145-wjz/file/download/document/1ef8fb28-e67c-63d6-93d3-fb42b720b124 | 2025-04-19 13:40:32 |
| DocumentDownload_linkname | Download (pdf, 236.26 KB) | 2025-04-19 13:40:32 |
Archiefversies (9 rijen)
Archiefrij 1 — 2025-11-21 15:27:21
fromFile: VWS-WOO-3324842-1025145-wjz-1f026c98-d81a-65d2-81ab-65673e0af118.zip
fromFilePath: archieven_files\VWS-WOO-3324842-1025145-wjz-1f026c98-d81a-65d2-81ab-65673e0af118.zip
documentName: VWS-WOO-08-638799.pdf
documentType: pdf
documentCompressedSize: 92674
documentSize: 241935
documentCompressRatio: 38.30532994399322
documentDateModified: 2025-10-09 13:13:44
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-11-21 15:27:21
lastSeen: 2025-11-21 15:27:21
text: 638799
Valneva COVID 19 candidate vaccine
Vaccine
Vero cell based inactivated vaccine VLA2001 with CpGIOlS adjuvant from Dynavax The virus has
been inactivated with BPL
preserving the native structure of the S protein The same platform has
also been used for a Japanese encephalitis vaccine appro...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: aac583287083f65fe4f1b88aa9f6259a966150e29d2b29d353398ec641a558b6
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:10.664062+00
Id: 6c8e0afb-a074-4320-8036-d2072351d064
textDigestSHA256: d3c3a2f177644d8fc14b90c50587e5aede90a98dde9dae2887911397be30b2ec
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-638799
Archiefrij 2 — 2025-11-21 15:15:27
fromFile: VWS-WOO-3324842-1025145-wjz-1f0a5111-2d47-6b86-928b-b52ef042b7e3.zip
fromFilePath: archieven_files\VWS-WOO-3324842-1025145-wjz-1f0a5111-2d47-6b86-928b-b52ef042b7e3.zip
documentName: VWS-WOO-08-638799.pdf
documentType: pdf
documentCompressedSize: 92674
documentSize: 241935
documentCompressRatio: 38.30532994399322
documentDateModified: 2025-10-09 13:13:44
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-11-21 15:15:27
lastSeen: 2025-11-21 15:15:27
text: 638799
Valneva COVID 19 candidate vaccine
Vaccine
Vero cell based inactivated vaccine VLA2001 with CpGIOlS adjuvant from Dynavax The virus has
been inactivated with BPL
preserving the native structure of the S protein The same platform has
also been used for a Japanese encephalitis vaccine appro...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: aac583287083f65fe4f1b88aa9f6259a966150e29d2b29d353398ec641a558b6
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: a3f700e8-e53f-4fc6-91ad-bab83e8a5370
textDigestSHA256: d3c3a2f177644d8fc14b90c50587e5aede90a98dde9dae2887911397be30b2ec
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-638799
Archiefrij 3 — 2025-09-08 18:28:42
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/temp/VWS-WOO-08-638799-Valneva_COVID.docx.pdf
documentName: VWS-WOO-08-638799-Valneva_COVID.docx.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 241935
documentCompressRatio: 0
documentDateModified: 2025-09-08 18:28:42
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-08 18:28:42
lastSeen: 2025-09-08 18:28:42
text: 638799
Valneva COVID 19candidate vaccine
Vaccine
Vero cellbased inactivated vaccine VLA2001 with CpGIOlS adjuvant from Dynavax The virus has
been inactivated with BPL preserving the native structure ofthe Sprotein The same platform has
also been used for aJapanese encephalitis vaccine approved bythe...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: aac583287083f65fe4f1b88aa9f6259a966150e29d2b29d353398ec641a558b6
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:10.749631+00
Id: folder_import_50657_63b6eecf5a23be2ef1a7fb613dbcef53
textDigestSHA256: b974def6407ee5f295349fbeddd5a0679631cd8e8cf98984b7e7bd2e91870174
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-638799
Archiefrij 4 — 2025-09-07 17:23:58
fromFile: folder_import
fromFilePath: /volume3/websites/openrijksoverheid/documenten_files/VWS-WOO-08-638799.pdf
documentName: VWS-WOO-08-638799.pdf
documentType: pdf
documentCompressedSize: 0
documentSize: 241935
documentCompressRatio: 0
documentDateModified: 2025-09-07 17:23:58
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-07 17:23:58
lastSeen: 2025-09-07 17:23:58
text: 638799
Valneva COVID 19candidate vaccine
Vaccine
Vero cellbased inactivated vaccine VLA2001 with CpGIOlS adjuvant from Dynavax The virus has
been inactivated with BPL preserving the native structure ofthe Sprotein The same platform has
also been used for aJapanese encephalitis vaccine approved bythe...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: aac583287083f65fe4f1b88aa9f6259a966150e29d2b29d353398ec641a558b6
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:10.664062+00
Id: folder_import_38843_1172fffb4f120b148a60f5bdbb8e66e2
textDigestSHA256: b974def6407ee5f295349fbeddd5a0679631cd8e8cf98984b7e7bd2e91870174
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-638799
Archiefrij 5 — 2025-09-04 16:18:27
fromFile: VWS-WOO-3324842-1025145-wjz-1f026c98-d81a-65d2-81ab-65673e0af118.1.zip
fromFilePath: ../../archieven_files/VWS-WOO-3324842-1025145-wjz-1f026c98-d81a-65d2-81ab-65673e0af118.1.zip
documentName: VWS-WOO-08-638799.pdf
documentType: pdf
documentCompressedSize: 92674
documentSize: 241935
documentCompressRatio: 38.30532994399322
documentDateModified: 2025-05-01 21:00:12
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-09-04 16:18:27
lastSeen: 2025-11-21 13:47:41
text: 638799
Valneva COVID 19candidate vaccine
Vaccine
Vero cellbased inactivated vaccine VLA2001 with CpGIOlS adjuvant from Dynavax The virus has
been inactivated with BPL preserving the native structure ofthe Sprotein The same platform has
also been used for aJapanese encephalitis vaccine approved bythe...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: aac583287083f65fe4f1b88aa9f6259a966150e29d2b29d353398ec641a558b6
documentDate: leeg!
ModifiedDate: 2025-12-10 19:42:20.178639+00
Id: VWS-WOO-3324842-1025145-wjz-1f026c98-d81a-65d2-81ab-65673e0af118.zip_1146
textDigestSHA256: b974def6407ee5f295349fbeddd5a0679631cd8e8cf98984b7e7bd2e91870174
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-638799
Archiefrij 6 — 2025-05-22 11:41:58
fromFile: VWS-WOO-3324842-1025145-wjz.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\VWS-WOO-3324842-1025145-wjz.zip
documentName: VWS-WOO-08-638799.pdf
documentType: pdf
documentCompressedSize: 92674
documentSize: 241935
documentCompressRatio: 38.30532994399322
documentDateModified: 2025-05-01 21:00:12
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-05-22 11:41:58
lastSeen: 2025-05-22 11:41:58
text: 638799
Valneva COVID 19candidate vaccine
Vaccine
Vero cellbased inactivated vaccine VLA2001 with CpGIOlS adjuvant from Dynavax The virus has
been inactivated with BPL preserving the native structure ofthe Sprotein The same platform has
also been used for aJapanese encephalitis vaccine approved bythe...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: b974def6407ee5f295349fbeddd5a0679631cd8e8cf98984b7e7bd2e91870174
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 421536
textDigestSHA256: b974def6407ee5f295349fbeddd5a0679631cd8e8cf98984b7e7bd2e91870174
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-638799
Archiefrij 7 — 2025-02-27 09:25:02
fromFile: 2023.057-VWS-WOO-3324842-1025145-wjz.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\2023.057-VWS-WOO-3324842-1025145-wjz.zip
documentName: VWS-WOO-08-638799-Valneva_COVID.docx.pdf
documentType: pdf
documentCompressedSize: 92581
documentSize: 241935
documentCompressRatio: 38.26688986711307
documentDateModified: 2024-12-10 12:00:54
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-27 09:25:02
lastSeen: 2025-02-27 09:25:02
text: 638799
Valneva COVID 19candidate vaccine
Vaccine
Vero cellbased inactivated vaccine VLA2001 with CpGIOlS adjuvant from Dynavax The virus has
been inactivated with BPL preserving the native structure ofthe Sprotein The same platform has
also been used for aJapanese encephalitis vaccine approved bythe...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: b974def6407ee5f295349fbeddd5a0679631cd8e8cf98984b7e7bd2e91870174
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 216206
textDigestSHA256: b974def6407ee5f295349fbeddd5a0679631cd8e8cf98984b7e7bd2e91870174
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-638799
Archiefrij 8 — 2025-02-18 12:36:08
fromFile: Besluit__dossier_nr_-84c6bdd4cd39ee1cd5963f471af3a703ee779472f5812544c3ddaaa2fdb0ccdf.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-84c6bdd4cd39ee1cd5963f471af3a703ee779472f5812544c3ddaaa2fdb0ccdf.zip
documentName: VWS-WOO-08-638799-Valneva_COVID.docx.pdf
documentType: pdf
documentCompressedSize: 92581
documentSize: 241935
documentCompressRatio: 38.26688986711307
documentDateModified: 2024-12-04 10:51:56
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:36:08
lastSeen: 2025-02-18 12:36:08
text: 638799
Valneva COVID 19candidate vaccine
Vaccine
Vero cellbased inactivated vaccine VLA2001 with CpGIOlS adjuvant from Dynavax The virus has
been inactivated with BPL preserving the native structure ofthe Sprotein The same platform has
also been used for aJapanese encephalitis vaccine approved bythe...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: b974def6407ee5f295349fbeddd5a0679631cd8e8cf98984b7e7bd2e91870174
documentDate: leeg!
ModifiedDate: 2025-12-10 19:41:04.555019+00
Id: 176783
textDigestSHA256: b974def6407ee5f295349fbeddd5a0679631cd8e8cf98984b7e7bd2e91870174
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-638799
Archiefrij 9 — 2025-02-18 12:18:03
fromFile: Besluit__dossier_nr_-1fe8423d31374d5a01c39858dd27b6af41ab93aac5ab9c6c9d8d782357487917.zip
fromFilePath: Z:\ARCHIEF WOO Documenten\archieven_files\Besluit__dossier_nr_-1fe8423d31374d5a01c39858dd27b6af41ab93aac5ab9c6c9d8d782357487917.zip
documentName: VWS-WOO-08-638799-Valneva_COVID.docx.pdf
documentType: pdf
documentCompressedSize: 92581
documentSize: 241935
documentCompressRatio: 38.26688986711307
documentDateModified: 2024-10-21 17:00:10
dossierReference: leeg!
dossierReferenceAlias: leeg!
createdDate: 2025-02-18 12:18:03
lastSeen: 2025-02-18 12:18:03
text: 638799
Valneva COVID 19candidate vaccine
Vaccine
Vero cellbased inactivated vaccine VLA2001 with CpGIOlS adjuvant from Dynavax The virus has
been inactivated with BPL preserving the native structure ofthe Sprotein The same platform has
also been used for aJapanese encephalitis vaccine approved bythe...
noTextDate: leeg!
ocrText: leeg!
documentIndicatedDate: leeg!
documentIndicatedDateCorrected: leeg!
documentMailAddresses: leeg!
documentMailAdresses: leeg!
digestSHA256: b974def6407ee5f295349fbeddd5a0679631cd8e8cf98984b7e7bd2e91870174
documentDate: leeg!
ModifiedDate: 2025-12-10 19:40:42.137456+00
Id: 52430
textDigestSHA256: b974def6407ee5f295349fbeddd5a0679631cd8e8cf98984b7e7bd2e91870174
ocrTextDigestSHA256: leeg!
extractedId: VWS-WOO-08-638799
(dit is ook een speeltuin)